136005-60-2

Upstream product

• 611-71-2 MANDELIC ACID 
• 135714-83-9 diethyl 2-(3,4-dimethoxyphenyl)-2-phenylpentane-1,5-dioate 
• 135714-84-0 1-ethyl hydrogen 2-(3,4-dimethoxyphenyl)-2-phenylpentane-dioate 
• 135714-99-7 ethyl 1,2,3,4-tetrahydro-6,7-dimethoxy-4-methylene-1-phenylnaphthalene-1-carboxylate 
• 97611-71-7 ethyl α-phenyl-3,4-dimethoxyphenylacetate 
• 2897-71-4 ethyl 1,2,3,4-tetrahydro-6,7-dimethoxy-4-oxo-1-phenylnaphthalene-1-carboxylate 
• 91-16-7 1,2-dimethoxybenzene 
• 135715-00-3 ethyl 6,7,8,9-tetrahydro-2,3-dimethoxy-8-oxo-5-phenyl-5H-benzocyclohepten-5-carboxylate 

Downstream Products

• 135715-02-5 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1,4-ethano-1H-3-benzazepine hydrobromide 
• 135715-01-4 2,3,4,5-tetrahydro-7,8-dimethoxy-1-phenyl-1,4-ethano-1H-3-benzazepine 
• 136005-59-9 2,3,4,5-tetrahydro-7,8-dimethoxy-1-phenyl-1,4-ethano-1H-3-benzazepin-2-one 

Relevant academic research and scientific papers

Bridged-ring Nitrogen Compounds. Part 10. Synthesis of Bridged 3-Benzazepine Derivatives as Conformationally Restricted Dopamine Analogues

Ethyl 3,4-dimethoxyphenyl(phenyl)acetate 7, (R=Et), made by an improved procedure, was converted into ethyl 1,2,3,4-tetrahydro-6,7-dimethoxy-4-oxo-1-phenylnaphthalene-1-carboxylate 15 which was used both in a synthesis of 2,3,4,5-tetrahydro-7,8-dihydroxy-